Global Amlodipine Besylate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Amlodipine Besylate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Amlodipine Besylate is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment ofHypertension and Coronary Artery Disease.
Amlodipine Besylate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Amlodipine Besylate market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from High Blood Pressure and Heart Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Amlodipine Besylate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Amlodipine Besylate key manufacturers include Pfizer, Mylan, Dr. Reddy's Laboratories, Apotex, Teva Pharmaceutical, Cipla, Hikma Pharmaceuticals, Strides Pharma and Upsher-Smith Laboratories, etc. Pfizer, Mylan, Dr. Reddy's Laboratories are top 3 players and held % sales share in total in 2022.
Amlodipine Besylate can be divided into 2.5mg Tablets, 5mg Tablets and 10mg Tablets,, etc. 2.5mg Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Amlodipine Besylate is widely used in various fields, such as High Blood Pressure and Heart Disease, etc. High Blood Pressure provides greatest supports to the Amlodipine Besylate industry development. In 2022, global % sales of Amlodipine Besylate went into High Blood Pressure filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Amlodipine Besylate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Pfizer
Mylan
Dr. Reddy's Laboratories
Apotex
Teva Pharmaceutical
Cipla
Hikma Pharmaceuticals
Strides Pharma
Upsher-Smith Laboratories
InvaGen Pharmaceuticals
Sun Pharmaceutical
Aurobindo Pharma
Lupin Pharmaceuticals
Zydus Pharmaceuticals
Oxford Pharm
Wockhardt
Epic Pharma
CR Pharmaceutical
Alkem Laboratories
MACLEODS
Segment by Type
2.5mg Tablets
5mg Tablets
10mg Tablets
High Blood Pressure
Heart Disease
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Amlodipine Besylate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Amlodipine Besylate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Amlodipine Besylate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Amlodipine Besylate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Amlodipine Besylate introduction, etc. Amlodipine Besylate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Amlodipine Besylate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Amlodipine Besylate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Amlodipine Besylate market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from High Blood Pressure and Heart Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Amlodipine Besylate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Amlodipine Besylate key manufacturers include Pfizer, Mylan, Dr. Reddy's Laboratories, Apotex, Teva Pharmaceutical, Cipla, Hikma Pharmaceuticals, Strides Pharma and Upsher-Smith Laboratories, etc. Pfizer, Mylan, Dr. Reddy's Laboratories are top 3 players and held % sales share in total in 2022.
Amlodipine Besylate can be divided into 2.5mg Tablets, 5mg Tablets and 10mg Tablets,, etc. 2.5mg Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Amlodipine Besylate is widely used in various fields, such as High Blood Pressure and Heart Disease, etc. High Blood Pressure provides greatest supports to the Amlodipine Besylate industry development. In 2022, global % sales of Amlodipine Besylate went into High Blood Pressure filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Amlodipine Besylate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Pfizer
Mylan
Dr. Reddy's Laboratories
Apotex
Teva Pharmaceutical
Cipla
Hikma Pharmaceuticals
Strides Pharma
Upsher-Smith Laboratories
InvaGen Pharmaceuticals
Sun Pharmaceutical
Aurobindo Pharma
Lupin Pharmaceuticals
Zydus Pharmaceuticals
Oxford Pharm
Wockhardt
Epic Pharma
CR Pharmaceutical
Alkem Laboratories
MACLEODS
Segment by Type
2.5mg Tablets
5mg Tablets
10mg Tablets
Segment by Application
High Blood Pressure
Heart Disease
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Amlodipine Besylate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Amlodipine Besylate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Amlodipine Besylate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Amlodipine Besylate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Amlodipine Besylate introduction, etc. Amlodipine Besylate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Amlodipine Besylate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.